JEOL to spin off medical equipment unit to Sysmex

JEOL Ltd. announced its decision to establish a new wholly-owned subsidiary for its medical equipment business, followed by a company split to transfer the business. Subsequently, all shares of this new company will be transferred to SYSMEX CORPORATION. The New Company, currently unnamed, will be headquartered in Musashimurayama City, Tokyo, with Kiyotaka Fujino as representative director, and is scheduled for establishment in early September 2025 with a stated capital of JPY 95 million.

The transaction, which will see the new subsidiary excluded from JEOL's consolidated financial reporting from the first quarter of the fiscal year ending March 2027, is designed to enhance the medical equipment business's sustainable growth and long-term corporate value under Sysmex’s expertise. Sysmex, a leading medical equipment manufacturer, will acquire the new company on April 1, 2026, subject to the company split taking effect. The transfer price will not be disclosed due to confidentiality obligations.

JEOL's medical equipment business, which began with automated clinical chemistry analyzers in 1972, generated net sales of JPY 15,418 million and an operating profit of JPY 662 million for the fiscal year ended March 2025. This strategic divestment is expected to create significant synergies in R&D, production, and business development for automated clinical chemistry analyzers, fostering further growth and strengthening competitiveness.